PlainRecalls
FDA Drug Moderate Class II Terminated

Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01

Reported: January 1, 2014 Initiated: October 22, 2013 #D-383-2014

Product Description

Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01

Reason for Recall

Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin

Details

Recalling Firm
Sandoz Incorporated
Units Affected
12,521 bottles
Distribution
Nationwide
Location
Broomfield, CO

Frequently Asked Questions

What product was recalled?
Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01. Recalled by Sandoz Incorporated. Units affected: 12,521 bottles.
Why was this product recalled?
Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin
Which agency issued this recall?
This recall was issued by the FDA Drug on January 1, 2014. Severity: Moderate. Recall number: D-383-2014.